Aquestive Therapeutics, Inc. Basic Shares Outstanding (Weighted Average)
Aquestive Therapeutics, Inc. (AQST) reported Basic Shares Outstanding (Weighted Average) of 124.99 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-11
- Aquestive Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 124.99M shares, a 25.84% increase year-over-year.
- Aquestive Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 122.61M shares, a 28.39% increase year-over-year.
- Aquestive Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 122.13M shares, a 33.87% increase year-over-year.
- Aquestive Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 110.58M shares, a 21.41% increase year-over-year.
- Aquestive Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 106.93M shares, a 23.29% increase from fiscal 2024.
- Aquestive Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 86.73M shares, a 41.58% increase from fiscal 2023.
- Aquestive Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 61.26M shares, a 25.69% increase from fiscal 2022.
- Aquestive Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 48.73M shares, a 27.99% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 124.99M shares 10-Q · filed 2026-08-11 | 123.81M shares 10-Q · filed 2026-08-11 | 123.25M shares derived: average of 3 quarters · filed 2026-08-11 | 120.08M shares derived: average of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | 122.61M shares 10-Q · filed 2026-05-13 | 122.37M shares derived: average of 2 quarters · filed 2026-05-13 | 118.44M shares derived: average of 3 quarters · filed 2026-05-13 | 113.66M shares derived: average of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | 122.13M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | 116.36M shares derived: average of 2 quarters · filed 2026-03-04 | 110.68M shares derived: average of 3 quarters · filed 2026-08-11 | 106.93M shares 10-K · filed 2026-03-04 |
| 2025-09-30 | 110.58M shares 10-Q · filed 2025-11-05 | 104.96M shares derived: average of 2 quarters · filed 2026-08-11 | 101.86M shares 10-Q · filed 2025-11-05 | 99.16M shares derived: average of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | 99.33M shares 10-Q · filed 2026-08-11 | 97.42M shares 10-Q · filed 2026-08-11 | 95.35M shares derived: average of 3 quarters · filed 2026-08-11 | 94.28M shares derived: average of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | 95.50M shares 10-Q · filed 2026-05-13 | 93.36M shares derived: average of 2 quarters · filed 2026-05-13 | 92.60M shares derived: average of 3 quarters · filed 2026-05-13 | 92.18M shares derived: average of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | 91.23M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | 91.16M shares derived: average of 2 quarters · filed 2026-03-04 | 91.08M shares derived: average of 3 quarters · filed 2026-03-04 | 86.73M shares 10-K · filed 2026-03-04 |
| 2024-09-30 | 91.08M shares 10-Q · filed 2025-11-05 | 91.00M shares derived: average of 2 quarters · filed 2025-11-05 | 85.22M shares 10-Q · filed 2025-11-05 | 80.72M shares derived: average of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | 90.91M shares 10-Q · filed 2025-08-11 | 82.26M shares 10-Q · filed 2025-08-11 | 77.26M shares derived: average of 3 quarters · filed 2025-08-11 | 74.12M shares derived: average of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | 73.61M shares 10-Q · filed 2025-05-12 | 70.44M shares derived: average of 2 quarters · filed 2025-05-12 | 68.52M shares derived: average of 3 quarters · filed 2025-05-12 | 65.73M shares derived: average of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | 67.27M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | 65.97M shares derived: average of 2 quarters · filed 2025-03-05 | 63.10M shares derived: average of 3 quarters · filed 2025-03-05 | 61.26M shares 10-K · filed 2025-03-05 |
| 2023-09-30 | 64.68M shares 10-Q · filed 2024-11-04 | 61.01M shares derived: average of 2 quarters · filed 2024-11-04 | 59.25M shares 10-Q · filed 2024-11-04 | 58.03M shares derived: average of 4 quarters · filed 2024-11-04 |
| 2023-06-30 | 57.35M shares 10-Q · filed 2024-08-06 | 56.49M shares 10-Q · filed 2024-08-06 | 55.81M shares derived: average of 3 quarters · filed 2024-08-06 | 55.22M shares derived: average of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | 55.63M shares 10-Q · filed 2024-05-07 | 55.04M shares derived: average of 2 quarters · filed 2024-05-07 | 54.50M shares derived: average of 3 quarters · filed 2024-05-07 | 52.24M shares derived: average of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | 54.45M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | 53.94M shares derived: average of 2 quarters · filed 2024-03-05 | 51.11M shares derived: average of 3 quarters · filed 2024-03-05 | 48.73M shares 10-K · filed 2024-03-05 |
| 2022-09-30 | 53.42M shares 10-Q · filed 2023-11-06 | 49.44M shares derived: average of 2 quarters · filed 2023-11-06 | 46.83M shares 10-Q · filed 2023-11-06 | 45.19M shares derived: average of 4 quarters · filed 2023-11-06 |
| 2022-06-30 | 45.46M shares 10-Q · filed 2023-08-07 | 43.48M shares 10-Q · filed 2023-08-07 | 42.45M shares derived: average of 3 quarters · filed 2023-08-07 | 41.64M shares derived: average of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | 41.47M shares 10-Q · filed 2023-05-02 | 40.94M shares derived: average of 2 quarters · filed 2023-05-02 | 40.37M shares derived: average of 3 quarters · filed 2023-05-02 | 39.54M shares derived: average of 4 quarters · filed 2023-05-02 |
| 2021-12-31 | 40.42M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | 39.82M shares derived: average of 2 quarters · filed 2023-03-31 | 38.90M shares derived: average of 3 quarters · filed 2023-03-31 | 38.08M shares 10-K · filed 2023-03-31 |
| 2021-09-30 | 39.22M shares 10-Q · filed 2022-11-01 | 38.15M shares derived: average of 2 quarters · filed 2022-11-01 | 37.30M shares 10-Q · filed 2022-11-01 | 36.42M shares derived: average of 4 quarters · filed 2022-11-01 |
| 2021-06-30 | 37.07M shares 10-Q · filed 2022-08-02 | 36.32M shares 10-Q · filed 2022-08-02 | 35.48M shares derived: average of 3 quarters · filed 2022-08-02 | 35.02M shares derived: average of 4 quarters · filed 2022-08-02 |
| 2021-03-31 | 35.56M shares 10-Q · filed 2022-05-04 | 34.69M shares derived: average of 2 quarters · filed 2022-05-04 | 34.34M shares derived: average of 3 quarters · filed 2022-05-04 | |
| 2020-12-31 | 33.83M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | 33.72M shares derived: average of 2 quarters · filed 2022-03-08 | 33.65M shares 10-K · filed 2022-03-08 | |
| 2020-09-30 | 33.62M shares 10-Q · filed 2021-11-02 | 33.59M shares 10-Q · filed 2021-11-02 | ||
| 2020-03-31 | 33.57M shares 10-Q · filed 2021-05-04 | |||
| 2019-09-30 | 25.03M shares 10-Q · filed 2019-11-05 | 25.01M shares derived: average of 2 quarters · filed 2019-11-05 | 24.99M shares 10-Q · filed 2019-11-05 | |
| 2019-06-30 | 24.98M shares 10-Q · filed 2019-08-06 | 24.97M shares 10-Q · filed 2019-08-06 | ||
| 2018-09-30 | 23.65M shares 10-Q · filed 2019-11-05 | 21.42M shares derived: average of 2 quarters · filed 2019-11-05 | 19.34M shares 10-Q · filed 2019-11-05 | |
| 2018-06-30 | 19.19M shares 10-Q · filed 2019-08-06 | 17.14M shares 10-Q · filed 2019-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |